Skip to main content
. 2020 Jun 11;15(6):e0234386. doi: 10.1371/journal.pone.0234386

Table 5. Multivariate logistic regression analysis of predictors of polypharmacy.

Variable Adjusted ‎OR (95% CI) p-value
Age (years) 0.32
    65–69 1
    70–74 1.13 (0.96–1.34)
    75 or more 0.54 (0.89–1.22)
Gender 0.013*
    Male 1
    Female 1.18 (1.03–1.34)
Body Mass Index (kg/m2) <0.001*
    Underweight (<18.5) 1
    Normal (18.5–24.9) 1.28 (0.79–2.09)
    Overweight (25–29.9) 1.39 (0.87–2.22)
    Obese (≥30) 1.66 (1.04–2.63)
No. of chronic conditions 0.01*
    Zero 1
    One 1.14 (0.82–1.60)
    Two 1.54 (1.03–2.31)
    Three 1.91 (1.17–3.12)
    Four or more 1.76 (1.00–3.14)
Hypertension <0.001*
    No 1
    Yes 1.71 (1.38–2.13)
Diabetes mellitus <0.001*
    No 1
    Yes 2.38 (1.97–2.87)
Dyslipidemia 0.008*
    No 1
    Yes 1.29 (1.06–1.56)
Cardiovascular disease a <0.001*
    No 1
    Yes 1.56 (1.25–1.95)
Asthma <0.001*
    No 1
    Yes 1.39 (1.13–1.72)
Gastroesophageal reflux disease 0.80
    No 1
    Yes 0.96 (0.75–1.24)
Mental health conditions c 0.33
    No 1
    Yes 1.22 (0.79–1.88)

OR = Odds ratio; CI = Confidence intervals

*statistically significant = p<0.05

a Ischemic heart disease, heart failure, arrhythmia, and stroke

b osteoarthritis and rheumatoid arthritis

c depression, anxiety and dementia